CompaniesByCap
PGNY
Progyny Inc. (PGNY)
NASDAQ · Healthcare

Progyny Inc. Revenue 2020–2025

Progyny Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Progyny Inc. revenue for the quarter ending March 31, 2026 was 328.5 M, a 1.38% increase year-over-year.
  • Progyny Inc. revenue for the twelve months ending March 31, 2026 was 1.3 B.
  • Progyny Inc. annual revenue for 2025 was 1.3 B, a 10.40% increase from 2024.
  • Progyny Inc. annual revenue for 2024 was 1.2 B, a 7.22% increase from 2023.
  • Progyny Inc. annual revenue for 2023 was 1.1 B, a 38.34% increase from 2022.
  • Progyny Inc. annual revenue for 2022 was 786.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Progyny Inc. (PGNY) — Frequently Asked Questions

Progyny Inc. (PGNY) is a publicly traded US company. It has a market capitalization of $2.22B. In fiscal 2025 it reported revenue of $1.29B and net income of $59M. Explore PGNY's stock price, financial statements, earnings history, margins and key ratios below.

What is Progyny Inc.'s market cap?

Progyny Inc. (PGNY) has a market capitalization of $2.22B.

What is the PGNY stock price?

PGNY trades at $25.89 (+0.23% on the day).

How much revenue does Progyny Inc. make?

Progyny Inc. reported revenue of $1.29B in fiscal 2025.

Is PGNY profitable?

In fiscal 2025, Progyny Inc. reported net income of $59M.

What is PGNY's P/E ratio?

Based on diluted EPS, PGNY has a price-to-earnings (P/E) ratio of about 39.8.